secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001171843-22-005358
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp Q2 revenue rises 24% to $25.1M, net income plunges to $345k from $2.7M
--------------------------------------------------------------------------------

- Revenue $25.1M (+24% YoY); net income $345k ($0.02 EPS) vs $2.7M ($0.18) prior year.
- Adjusted EBITDA $2.6M, down from $3.8M; operating income $473k vs $2.0M.
- System-wide sales $106M (+21%); system-wide comp sales +8%; total clinics 769 (+33 net).
- Cash $9.4M at June 30, down from $19.5M at Dec 31 due to clinic acquisitions and greenfields.
- FY 2022 guidance reaffirmed: revenue $98-102M, Adj EBITDA $12-14M, franchised openings 110-130.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/0001171843-22-005358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/f8k_080422.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-005358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer